APA (7th ed.) Citation

CS, D., EE, W., S, P., SR, B., K, Z., DR, S., . . . R, J. (2023). Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? The Laryngoscope, 133(1), 2. https://doi.org/10.1002/lary.30180

Chicago Style (17th ed.) Citation

CS, Derkay, et al. "Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?" The Laryngoscope 133, no. 1 (2023): 2. https://doi.org/10.1002/lary.30180.

MLA (9th ed.) Citation

CS, Derkay, et al. "Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?" The Laryngoscope, vol. 133, no. 1, 2023, p. 2, https://doi.org/10.1002/lary.30180.